Skip to main content
Equibles

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in XFOR — X4 Pharmaceuticals, Inc

CIK 884546 SAN FRANCISCO, CA
Back to XFOR Full portfolio

Position in XFOR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,229,442
+$953,769 QoQ
Shares Held
263,264
+294.4% QoQ
Ownership
0.266%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 89 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XFOR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. XFOR ranks #215 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,041,282 $1,013,966,007
2 REGN
Regeneron Pharmaceuticals, Inc.
 846,306 $527,705,642
3 RVMD
Revolution Medicines, Inc.
 1,917,025 $359,020,441
4 MRNA
Moderna, Inc.
 4,838,884 $338,867,045
5 ALNY
Alnylam Pharmaceuticals, Inc.
 755,377 $227,391,137
6 INCY
Incyte Corp
 1,692,439 $191,854,884
7 RPRX
Royalty Pharma plc
 3,083,528 $172,893,414
8 CYTK
Cytokinetics Inc
 1,565,781 $133,388,883

All Filings in XFOR

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,229,442 263,264
2026-03-31 $275,673 66,749
2025-12-31 $267,152 66,788
2025-03-31 $113,640 481,528
2024-12-31 $321,644 438,208
2024-09-30 $293,161 438,208
2024-06-30 $254,160 438,208
2024-03-31 $450,141 323,843
2023-12-31 $271,704 323,843
2023-09-30 $352,988 323,843
2023-06-30 $628,255 323,843
2023-03-31 $36,875 42,386
2022-12-31 $42,089 42,386
2022-09-30 $72,480 42,386
2021-03-31 $358,804 41,673
2020-12-31 $267,957 41,673
2020-09-30 $259,081 38,269
2020-06-30 $384,291 41,233
2020-03-31 $393,279 39,328